Mylan (Nasdaq: MYL) will pay a premium of approximately $7.2 billion in cash and stock to acquire Swedish drug maker Media. Shares of the pharmaceutical firm plummeted $9.12 to close at $41.42.
Mylan to pay premium for Meda
February 11, 2016 at 18:06 PM EST